Literature DB >> 18057936

[Hepatocellular carcinoma in the non-cirrhotic liver].

M Evert1, F Dombrowski.   

Abstract

Of hepatocellular carcinomas (HCC), 15-20% occur in the non-cirrhotic liver. All factors which cause HCC when liver cirrhosis (LC) is present, can also lead to HCC without LC. On the basis of the relative frequency, HCC can be roughly differentiated into 3 groups: 1) HCC, rarely occurring without cirrhosis (e.g. virus hepatitis, alcohol abuse). 2) HCC, frequently occurring without LC (alpha1-antitrypsin deficiency, hemochromatosis, non-alcoholic fatty liver disease). 3) HCC, consistently occurring without LC (glycogen storage disease type 1, consumption of oral contraceptives/anabolic steroids). In groups 1 and 2 the level of hepatocellular toxicity necessary to reach LC is not yet achieved but the carcinogenic effect is already strong enough to induce HCC, possibly owing to the influence of additional carcinogens or host factors. In group 3, the carcinogenic effect is mediated by a long-standing alteration of the hepatocellular metabolism that is of low toxic effect and does not lead to cell death, but is nevertheless carcinogenic. In these cases, the initial formation of hepatocellular adenomas that subsequently transform into HCC is a common finding (adenoma-carcinoma sequence).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18057936     DOI: 10.1007/s00292-007-0953-3

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  36 in total

Review 1.  Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular, and metabolic changes.

Authors:  P Bannasch
Journal:  Prog Liver Dis       Date:  1996

2.  Is heterozygous alpha-1-antitrypsin deficiency type PIZ a risk factor for primary liver carcinoma?

Authors:  H Zhou; M E Ortiz-Pallardó; Y Ko; H P Fischer
Journal:  Cancer       Date:  2000-06-15       Impact factor: 6.860

3.  Hepatocellular adenoma. Its transformation to carcinoma in a user of oral contraceptives.

Authors:  H Tesluk; J Lawrie
Journal:  Arch Pathol Lab Med       Date:  1981-06       Impact factor: 5.534

Review 4.  Iron, hemochromatosis, and hepatocellular carcinoma.

Authors:  Kris V Kowdley
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

5.  Hepatocellular neoplasms induced by low-number pancreatic islet transplants in autoimmune diabetic BB/Pfd rats.

Authors:  Frank Dombrowski; Chantal Mathieu; Matthias Evert
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

Review 6.  Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions.

Authors:  Isela Velazquez; Blanche P Alter
Journal:  Am J Hematol       Date:  2004-11       Impact factor: 10.047

7.  Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study.

Authors:  J A Davila; R O Morgan; Y Shaib; K A McGlynn; H B El-Serag
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

8.  Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients.

Authors:  U C Nzeako; Z D Goodman; K G Ishak
Journal:  Am J Clin Pathol       Date:  1996-01       Impact factor: 2.493

9.  Hepatocellular carcinoma arising from nonalcoholic steatohepatitis: report of two cases.

Authors:  Seikan Hai; Shoji Kubo; Taichi Shuto; Hiromu Tanaka; Shigekazu Takemura; Takatsugu Yamamoto; Akishige Kanazawa; Masao Ogawa; Kazuhiro Hirohashi; Kenichi Wakasa
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

10.  Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients.

Authors:  F Trevisani; P E D'Intino; P Caraceni; M Pizzo; G F Stefanini; A Mazziotti; G L Grazi; G Gozzetti; G Gasbarrini; M Bernardi
Journal:  Cancer       Date:  1995-05-01       Impact factor: 6.860

View more
  18 in total

Review 1.  Nutrition and Hepatocellular Cancer.

Authors:  Kerstin Schütte; Christian Schulz; Peter Malfertheiner
Journal:  Gastrointest Tumors       Date:  2015-11-18

Review 2.  [Molecular and metabolic changes in human clear cell liver foci].

Authors:  S Ribback; D F Calvisi; A Cigliano; J Rausch; C-D Heidecke; M Birth; F Dombrowski
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

3.  Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: a heuristically highly relevant phenotype.

Authors:  Peter Bannasch
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

Review 4.  Fortuitously discovered liver lesions.

Authors:  Christoph F Dietrich; Malay Sharma; Robert N Gibson; Dagmar Schreiber-Dietrich; Christian Jenssen
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

5.  Hepatitis C virus-associated primary hepatocellular carcinoma in non-cirrhotic patients.

Authors:  Mazen Albeldawi; Mohamed Soliman; Rocio Lopez; Nizar N Zein
Journal:  Dig Dis Sci       Date:  2012-06-14       Impact factor: 3.199

Review 6.  [Hepatocellular tumours in noncirrhotic liver tissue].

Authors:  D Goltz; H-P Fischer
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

7.  Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers.

Authors:  Matthew M Yeh; Hubert Darius-J Daniel; Michael Torbenson
Journal:  Mod Pathol       Date:  2009-11-20       Impact factor: 7.842

8.  [Diagnosis of and therapy for hepatocellular carcinoma].

Authors:  T F Greten; N P Malek; S Schmidt; J Arends; P Bartenstein; W Bechstein; T Bernatik; M Bitzer; A Chavan; M Dollinger; D Domagk; O Drognitz; M Düx; S Farkas; G Folprecht; P Galle; M Geißler; G Gerken; D Habermehl; T Helmberger; K Herfarth; R T Hoffmann; M Holtmann; P Huppert; T Jakobs; M Keller; J Klempnauer; F Kolligs; J Körber; H Lang; F Lehner; F Lordick; A Lubienski; M P Manns; A Mahnken; M Möhler; C Mönch; P Neuhaus; C Niederau; M Ocker; G Otto; P Pereira; G Pott; J Riemer; K Ringe; U Ritterbusch; E Rummeny; P Schirmacher; H J Schlitt; K Schlottmann; V Schmitz; A Schuler; H Schulze-Bergkamen; D von Schweinitz; D Seehofer; H Sitter; C P Straßburg; C Stroszczynski; D Strobel; A Tannapfel; J Trojan; I van Thiel; A Vogel; F Wacker; H Wedemeyer; H Wege; A Weinmann; C Wittekind; B Wörmann; C J Zech
Journal:  Z Gastroenterol       Date:  2013-11-15       Impact factor: 2.000

9.  Development of hepatocellular carcinoma associated with anabolic androgenic steroid abuse in a young bodybuilder: a case report.

Authors:  Aline Hardt; Dirk Stippel; Margarete Odenthal; Arnulf H Hölscher; Hans-Peter Dienes; Uta Drebber
Journal:  Case Rep Pathol       Date:  2012-07-05

Review 10.  Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements.

Authors:  Abhilash Perisetti; Hemant Goyal; Rachana Yendala; Ragesh B Thandassery; Emmanouil Giorgakis
Journal:  World J Gastroenterol       Date:  2021-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.